File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis.
  • Basic View
  • Metadata View
  • XML View
TitleComparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis.
 
AuthorsChua, DT1
Wu, SX
Lee, V
Tsang, J
 
Issue Date2009
 
PublisherBioMed Central Ltd.. The Journal's web site is located at http://www.headandneckoncology.org
 
CitationHead & Neck Oncology, 2009, v. 1, p. 13 [How to Cite?]
 
AbstractBACKGROUND: Local failure is an important cause of morbidity and mortality in nasopharyngeal carcinoma (NPC). Although surgery or brachytherapy may be feasible in selected cases, most patients with local failure require external beam re-irradiation. Stereotactic radiation using single or multiple fractions have been employed in re-irradiation of NPC, but the optimal fractionation scheme and dose are not clear. METHODS: Records of 125 NPC patients who received salvage stereotactic radiation were reviewed. A matched-pair design was used to select patients with similar prognostic factors who received stereotactic re-irradiation using single fraction (SRS) or multiple fractions (SRM). Eighty-six patients were selected with equal number in SRS and SRM groups. All patients were individually matched for failure type (persistent or recurrent), rT stage (rT1-2 or rT3-4), and tumor volume (< or = 5 cc, >5-10 cc, or >10 cc). Median dose was 12.5 Gy in single fraction by SRS, and 34 Gy in 2-6 fractions by SRM. RESULTS: Local control rate was better in SRM group although overall survival rates were similar. One- and 3-year local failure-free rates were 70% and 51% in SRS group compared with 91% and 83% in SRM group (p = 0.003). One- and 3-year overall survival rates were 98% and 66% in SRS group compared with 78% and 61% in SRM group (p = 0.31). The differences in local control were mainly observed in recurrent or rT2-4 disease. Incidence of severe late complications was 33% in SRS group vs. 21% in SRM group, including brain necrosis (16% vs. 12%) and hemorrhage (5% vs. 2%). CONCLUSION: Our study showed that SRM was superior to SRS in salvaging local failures of NPC, especially in the treatment of recurrent and rT2-4 disease. In patient with local failure of NPC suitable for stereotactic re-irradiation, use of fractionated treatment is preferred.
 
ISSN1758-3284
2013 SCImago Journal Rankings: 0.729
 
ISI Accession Number IDWOS:000208107000013
 
DC FieldValue
dc.contributor.authorChua, DT
 
dc.contributor.authorWu, SX
 
dc.contributor.authorLee, V
 
dc.contributor.authorTsang, J
 
dc.date.accessioned2010-05-31T03:33:24Z
 
dc.date.available2010-05-31T03:33:24Z
 
dc.date.issued2009
 
dc.description.abstractBACKGROUND: Local failure is an important cause of morbidity and mortality in nasopharyngeal carcinoma (NPC). Although surgery or brachytherapy may be feasible in selected cases, most patients with local failure require external beam re-irradiation. Stereotactic radiation using single or multiple fractions have been employed in re-irradiation of NPC, but the optimal fractionation scheme and dose are not clear. METHODS: Records of 125 NPC patients who received salvage stereotactic radiation were reviewed. A matched-pair design was used to select patients with similar prognostic factors who received stereotactic re-irradiation using single fraction (SRS) or multiple fractions (SRM). Eighty-six patients were selected with equal number in SRS and SRM groups. All patients were individually matched for failure type (persistent or recurrent), rT stage (rT1-2 or rT3-4), and tumor volume (< or = 5 cc, >5-10 cc, or >10 cc). Median dose was 12.5 Gy in single fraction by SRS, and 34 Gy in 2-6 fractions by SRM. RESULTS: Local control rate was better in SRM group although overall survival rates were similar. One- and 3-year local failure-free rates were 70% and 51% in SRS group compared with 91% and 83% in SRM group (p = 0.003). One- and 3-year overall survival rates were 98% and 66% in SRS group compared with 78% and 61% in SRM group (p = 0.31). The differences in local control were mainly observed in recurrent or rT2-4 disease. Incidence of severe late complications was 33% in SRS group vs. 21% in SRM group, including brain necrosis (16% vs. 12%) and hemorrhage (5% vs. 2%). CONCLUSION: Our study showed that SRM was superior to SRS in salvaging local failures of NPC, especially in the treatment of recurrent and rT2-4 disease. In patient with local failure of NPC suitable for stereotactic re-irradiation, use of fractionated treatment is preferred.
 
dc.description.natureLink_to_subscribed_fulltext
 
dc.identifier.citationHead & Neck Oncology, 2009, v. 1, p. 13 [How to Cite?]
 
dc.identifier.epage13
 
dc.identifier.hkuros158402
 
dc.identifier.isiWOS:000208107000013
 
dc.identifier.issn1758-3284
2013 SCImago Journal Rankings: 0.729
 
dc.identifier.pmid19463191
 
dc.identifier.scopuseid_2-s2.0-77957964200
 
dc.identifier.spage13
 
dc.identifier.urihttp://hdl.handle.net/10722/58607
 
dc.identifier.volume1
 
dc.languageeng
 
dc.publisherBioMed Central Ltd.. The Journal's web site is located at http://www.headandneckoncology.org
 
dc.publisher.placeUnited Kingdom
 
dc.relation.ispartofHead & neck oncology
 
dc.titleComparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis.
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Chua, DT</contributor.author>
<contributor.author>Wu, SX</contributor.author>
<contributor.author>Lee, V</contributor.author>
<contributor.author>Tsang, J</contributor.author>
<date.accessioned>2010-05-31T03:33:24Z</date.accessioned>
<date.available>2010-05-31T03:33:24Z</date.available>
<date.issued>2009</date.issued>
<identifier.citation>Head &amp; Neck Oncology, 2009, v. 1, p. 13</identifier.citation>
<identifier.issn>1758-3284</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/58607</identifier.uri>
<description.abstract>BACKGROUND: Local failure is an important cause of morbidity and mortality in nasopharyngeal carcinoma (NPC). Although surgery or brachytherapy may be feasible in selected cases, most patients with local failure require external beam re-irradiation. Stereotactic radiation using single or multiple fractions have been employed in re-irradiation of NPC, but the optimal fractionation scheme and dose are not clear. METHODS: Records of 125 NPC patients who received salvage stereotactic radiation were reviewed. A matched-pair design was used to select patients with similar prognostic factors who received stereotactic re-irradiation using single fraction (SRS) or multiple fractions (SRM). Eighty-six patients were selected with equal number in SRS and SRM groups. All patients were individually matched for failure type (persistent or recurrent), rT stage (rT1-2 or rT3-4), and tumor volume (&lt; or = 5 cc, &gt;5-10 cc, or &gt;10 cc). Median dose was 12.5 Gy in single fraction by SRS, and 34 Gy in 2-6 fractions by SRM. RESULTS: Local control rate was better in SRM group although overall survival rates were similar. One- and 3-year local failure-free rates were 70% and 51% in SRS group compared with 91% and 83% in SRM group (p = 0.003). One- and 3-year overall survival rates were 98% and 66% in SRS group compared with 78% and 61% in SRM group (p = 0.31). The differences in local control were mainly observed in recurrent or rT2-4 disease. Incidence of severe late complications was 33% in SRS group vs. 21% in SRM group, including brain necrosis (16% vs. 12%) and hemorrhage (5% vs. 2%). CONCLUSION: Our study showed that SRM was superior to SRS in salvaging local failures of NPC, especially in the treatment of recurrent and rT2-4 disease. In patient with local failure of NPC suitable for stereotactic re-irradiation, use of fractionated treatment is preferred.</description.abstract>
<language>eng</language>
<publisher>BioMed Central Ltd.. The Journal&apos;s web site is located at http://www.headandneckoncology.org</publisher>
<relation.ispartof>Head &amp; neck oncology</relation.ispartof>
<title>Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis.</title>
<type>Article</type>
<description.nature>Link_to_subscribed_fulltext</description.nature>
<identifier.pmid>19463191</identifier.pmid>
<identifier.scopus>eid_2-s2.0-77957964200</identifier.scopus>
<identifier.hkuros>158402</identifier.hkuros>
<identifier.volume>1</identifier.volume>
<identifier.spage>13</identifier.spage>
<identifier.epage>13</identifier.epage>
<identifier.isi>WOS:000208107000013</identifier.isi>
<publisher.place>United Kingdom</publisher.place>
</item>
Author Affiliations
  1. The University of Hong Kong